-
Obese Kidney Donors: Impact of Opioid-Minimization Using Ketorolac-Based Pain Management Protocol Following Robotically Assisted, Laparoscopic Living Donor Nephrectomy.
-
Obesity Is an Important Factor in Deceased but Not Living Donor Kidney Transplants.
-
Obesity Predicts New-Onset Diabetes After Live Kidney Donation.
-
Objective Assessment of Graft Metabolism and Function During Ex Vivo Liver Perfusion.
-
Occult Hepatitis C Virus in Recipients of Kidney Transplantation: Prevalence and Clinical Implications.
-
Omega 3 Attenuates Ischemia Reperfusion Renal Injury via Enhancement of Autophagy Flux.
-
On the Pathogenesis of Post-Transplant Diarrhea in Kidney Transplant Recipients.
-
Once-Daily versus Twice-Daily Tacrolimus in Living Kidney Transplantation: A Multicenter, Parallel Group, Open-Label, 5-Year, Randomized Non-Inferiority Trial.
-
One Year Outcomes of Low-Dose vs Very Low-Dose Extended-Release Tacrolimus/Mycophenolate mofetil in De Novo Kidney Transplantation: A Multi-Center Randomized Controlled Trial.
-
One-Year Graft and Patient Survival of Deceased Donor Kidney Transplants Under KAS.
-
Online Patient Resources for Deceased Donor and Live Donor Kidney Recipients: A Comparative Analysis of Readability.
-
Operational Tolerance in Intestinal Transplantation: A Proven Possibility.
-
Opioid and Opioid Substitution Therapy in Liver Transplant Candidates: A Survey of Center Policies and Practices.
-
OPO Performance Metrics: Relationship with Kidney Transplant Program Performance Metrics and Kidney Utilization.
-
OPO-Wide Waitlist Size and Deceased Donor Kidney Transplant Rate.
-
Optimal Induction Therapy for Kidney Transplantation in Previous Heart Transplant Recipients: Analysis of OPTN/UNOS Registry.
-
Optimization of Extended-Release Tacrolimus Dose with Mycophenolate Mofetile Based Immunosuppression in De Novo Kidney Transplant Recipients: 2 Years Outcome.
-
Optimization of Pancreatic Islet-Like Clusters from hiPSCs for Cell Therapy in Type 1 Diabetes.
-
Optimizing Support for Living Kidney Donors: Insights from a Prospective Study.
-
Optimizing Survival Outcomes for Advanced Age Patients Undergoing Liver Transplant.
-
Organs with Extended Cold Ischemia Time May Offer Aged Kidney Transplant Recipients New Options in an Expanded Donor Pool.
-
Ornithine Transcarbamylase Deficiency (OTC) in the Donor Liver, the Importance of Ascertaining the Cause of Death in the Brain Dead Donor.
-
Orthotopic Liver Transplantation of Xenogeneic Livers Repopulated with Autologous Hepatocytes: Proof of Normal Function and Consistent Survival.
-
Outcome After Living Donor Liver Transplantation for Hepatocellular Carcinoma in Elderly Patients > 65 Years: Assessing the Long Term Survival.
-
Outcome and Risk Factors of Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation.
-
Outcome of ABO-Incompatible Kidney Transplantation After Stratified Desensitization.
-
Outcome of Adult Living Donor Renal Transplants in Different Era: Analysis of UNOS Database.
-
Outcome of Kidney Transplantation from Deceased Octogenarian Donors.
-
Outcome of Liver Transplantation in Patients with Prior Bariatric Surgery.
-
Outcome of Living Donor Transplantation in Pediatric Recipients Over the Last Three Decades by Era: An Analysis of UNOS Database.
-
Outcome of Living-Donor Kidney Transplantation in Cross-Match-Positive Recipients at a Single Center.
-
Outcome of Systemic Monitoring of DSA and Protocol Management to Optimize Renal Allograft Outcome in a Single Transplant Center.
-
Outcomes After Cholecystectomy in Patients with End Stage Renal Disease.
-
Outcomes After Hysterectomy in Patients with End Stage Renal Disease.
-
Outcomes After Lung Transplant: Being a Teenager Does Not Stop at Age 18.
-
Outcomes and Risk Factors for Graft Loss: Lessons Learned from More Than 1,056 Pediatric Kidney tx at a Single Center.
-
Outcomes Following Cholecystectomy in Kidney Transplant Recipients.
-
Outcomes Following Colectomy in Kidney Transplant Recipients.
-
Outcomes Following Colectomy in Liver Transplant Recipients.
-
Outcomes Following Hysterectomy in Kidney Transplant Recipients.
-
Outcomes Following Reduction of Immunosuppression in Solid Organ Transplant Recipients with Cryptococcosis.
-
Outcomes Following Solitary Pancreas Transplantation – Do Steroids Matter?
-
Outcomes Following Transplantation for Hepatocellular Carcinoma.
-
Outcomes for Plasma Cell Rich Rejection in Pediatric Kidney Transplant Patients.
-
Outcomes from a Multinational Randomised Controlled Trial Comparing Normothermic Machine Perfusion with Static Cold Storage in Human Liver Transplantation.
-
Outcomes of 100 ABO Incompatible Kidney Transplants: A Single US Center Experience.
-
Outcomes of Active Screening for Carbapenem-Resistant Enterobacteriaceae among Liver Transplant Recipients.
-
Outcomes of Combined Liver/Lung Transplantation for Cystic Fibrosis Using SRTR Analysis.
-
Outcomes of Deceased Donor Kidney Transplantation in Elderly Recipients Aged 70 Years and Older.
-
Outcomes of Hand Assisted Laparoscopic Right Donor Nephrectomy, Single Center Experience.
-
Outcomes of Infrainguinal Revascularization in Renal Transplant Patients.
-
Outcomes of Kidney Transplantation After Primary, Repeat and Kidney After Nonrenal Solid Organ Transplantation: 10 Years UNOS Database Analysis.
-
Outcomes of Kidney Transplantation Using Deceased Diabetic Donors.
-
Outcomes of Moderately to Severely Steatotic Grafts in Liver Transplantation: A Meta-Analysis.
-
Outcomes of Organs Transplants When the Donor Is a Prior Recipient.
-
Outcomes of Protocol Allograft Kidney Biopsy in DeNovo Donor Specific Antibodies.
-
Outcomes of Recurrent Clostridium difficile Infection in Solid Organ Transplant Recipients.
-
Outcomes of Renal Disease Related to Monoclonal Gammopathy After Kidney Transplantation: A Single Center Experience.
-
Outcomes with Kidney Transplant from Deceased Donors with Acute Kidney Injury and Prolonged Cold Ischemia Time: UNOS Analysis.
-
Outcomes with Steroid Avoidance Regimen After Kidney Transplantation without Induction Immunosuppression.
-
Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Dosing.
2017 American Transplant Congress
April 29-May 3, 2017 in Chicago, IL